Sermorelin · Research brief
Sermorelin Research Reporting Standards — What to Verify
Short answer
Sermorelin Research Reporting Standards: What to Verify Before Buying Wholesale Reporting standards for sermorelin research material come down to documentation a buyer can independently check: a batch-specific certificate of analysis that names the analytical methods used, reports chromatographic purity by HPLC, confirms identity by mass spectrometry, separates purity from net peptide content, and ties every figure to a lot number…
Sermorelin Research Reporting Standards: What to Verify Before Buying Wholesale
Reporting standards for sermorelin research material come down to documentation a buyer can independently check: a batch-specific certificate of analysis that names the analytical methods used, reports chromatographic purity by HPLC, confirms identity by mass spectrometry, separates purity from net peptide content, and ties every figure to a lot number printed on the vial itself. If the paperwork cannot be matched to the physical unit in front of you, it is marketing collateral, not data. For a wholesale buyer stocking research compounds, that single test — does the document match the vial? — separates a defensible supply chain from a liability.
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of human growth hormone-releasing hormone, which is why it sits alongside other GHRH-analog and secretagogue compounds in research catalogs. It is a research-use-only material. Nothing below describes human use, preparation, or administration, and none of it should be read as guidance for anything other than evaluating supplier documentation.
What a complete documentation package actually contains
A usable analytical file for any research peptide has several parts, and most thin COAs are thin because they include only the first one.
The identity section should state the sequence or molecular formula and the theoretical molecular weight, then show the observed mass from mass spectrometry. A number close to theoretical is what confirms you received the compound named on the label rather than a truncated or misfolded variant.
The purity section should name the method — reversed-phase HPLC is standard — and ideally reference the gradient and detection wavelength. Purity reported without a method is a number with no unit behind it.
The quantitative section should report peptide content separately from chromatographic purity, because they measure different things. More on that below.
The safety and residuals section covers what else is in the vial: water content, residual solvents from synthesis, counterion content such as acetate or trifluoroacetate, heavy metals, bacterial endotoxin, and microbial limits. Each of these is a distinct assay. A supplier that reports one of them and calls the material "fully tested" is stretching the word.
Finally, the administrative section: lot number, manufacture date, retest or expiry date, storage conditions, and the name of the laboratory that ran the work. Without these, nothing in the file is traceable.
Purity and peptide content are not the same number
This is the most common misreading in the wholesale market, and it is worth understanding before you evaluate a single supplier.
Chromatographic purity tells you what proportion of the peptide-related material in the sample is the target peptide, as resolved by HPLC. A high purity figure means few related impurities — deletion sequences, oxidation products, synthesis by-products.
Peptide content tells you what proportion of the total mass in the vial is actually peptide, as opposed to water, counterions, and residual salts. A lyophilized powder can be highly pure by HPLC and still contain a meaningful fraction of non-peptide mass, because that is simply how lyophilized peptide salts behave.
Both numbers matter for research reporting. A lab documenting a study needs to know what it weighed out and what fraction of that mass was the compound of interest. A wholesale buyer needs both numbers because a supplier reporting only purity is reporting the more flattering of the two. Ask for both, and ask which assay produced the content figure — amino acid analysis and nitrogen determination are the usual approaches, and a supplier who cannot name the method probably did not run it.
The practical concentration framework a research buyer works in is milligrams of peptide per milliliter of solution. That is the ceiling of what any responsible supplier will discuss. Real Peptides does not provide preparation, reconstitution, or dosing guidance for any catalog item, because these are research-use-only compounds and that guidance is the researcher's own domain.
Identity confirmation, and why one test is never enough
Mass spectrometry confirms molecular weight. It does not, on its own, confirm sequence order — two peptides with the same amino acid composition in different order share a mass. For most commercial research material, mass confirmation plus HPLC retention behavior against a reference is the working standard, and that is reasonable for catalog-scale supply. Where a research program needs sequence-level confirmation, that is an additional analysis the end lab typically commissions.
What a buyer should watch for is the substitution of one test for the whole picture. A file showing a clean chromatogram and nothing else tells you the material is homogeneous, not that it is the right molecule. A file showing a mass spec trace and nothing else tells you the right molecule is present, not that it is present at high purity. The pair is the minimum. Anything reported as a single number with no underlying trace attached is a claim rather than a result.
The same logic applies across GHRH-analog and secretagogue research material generally. Whether a lab is working with Tesamorelin, CJC-1295 No DAC, or Ipamorelin, the documentation standard does not change by compound. It changes by supplier.
Lot traceability, storage claims, and stability reporting
A certificate of analysis is a statement about one batch on one date. It is not a statement about the supplier, the product line, or the next shipment. That distinction is where traceability earns its keep.
Every unit you receive should carry a lot identifier that appears on the vial, on the packaging, and on the COA you can pull up independently. If a downstream question ever arises about a specific unit, that chain is the only thing that lets you answer it. Suppliers who publish one COA per product rather than one per batch have collapsed that chain, and rebuilding it after the fact is not possible.
Storage and stability reporting deserve equal scrutiny. A COA that states recommended storage conditions for lyophilized material is standard. A COA that asserts a long shelf life with no stability data behind it is an assumption dressed as a specification. Ask whether retest dates are based on actual stability study data or on a default interval. Either answer can be acceptable; only one of them is honest when stated plainly.
Shipping conditions belong in the same conversation. Cold-chain handling, transit duration, and whether temperature excursions are monitored all affect what arrives. A supplier that can describe its fulfillment process specifically is easier to trust than one that describes it warmly.
Thin file versus complete file: what to compare
When you request documentation from two suppliers, put the responses side by side before you compare prices. The gaps are usually obvious once they are in columns.
| Documentation element | Thin file — proceed carefully | Complete file — what to require |
|---|---|---|
| COA scope | One generic PDF covering the product line | Batch-specific, matched to the lot on the vial |
| Purity | A bare percentage, no method named | HPLC purity with method stated and chromatogram attached |
| Identity | Asserted on the label only | Mass spectrometry result against theoretical mass |
| Peptide content | Not reported, or conflated with purity | Reported separately, with assay method named |
| Contaminant testing | "Tested" with no panel described | Named panel: residuals, heavy metals, endotoxin, microbial limits, water content |
| Access | COA sent on request, or sold as an add-on | Publicly verifiable, checkable before you order |
| Traceability | No lot number on the document | Lot number, date, retest date, testing lab identified |
| Pricing transparency | Tier pricing hidden behind a sales call | Published wholesale structure disclosed in the application process |
Two industry practices belong on the avoid list regardless of who is doing them. The first is charging for a certificate of analysis — testing documentation that costs extra is a signal about how the supplier views testing. The second is purity claimed without any verifiable underlying record. Neither practice is illegal and neither is rare; both are reasons to keep looking.
Questions to resolve with your own counsel
This section is informational and is not legal advice. Regulatory classification, resale authority, labeling obligations, and professional licensing rules for research compounds vary by jurisdiction and change over time, and nothing here should be treated as a conclusion about your situation.
The productive approach is to bring questions to your attorney and, where relevant, your state board rather than to assume an answer from a supplier's website. Reasonable questions include: how research-use-only material is classified for the activities my business actually conducts; what labeling and recordkeeping obligations attach to holding or reselling it; whether my business structure or professional licensure creates obligations that a general reseller would not have; what my documentation retention requirements are; and what my insurance carrier expects of a supply chain in this category.
A supplier can tell you what testing it performs and what documentation it provides. A supplier cannot tell you what you are permitted to do with the material. Any vendor that offers a confident legal conclusion about your business is doing something outside its competence, and that is itself useful information about the vendor.
What Real Peptides does differently
Real Peptides builds its wholesale supply around documentation that a buyer can check without asking permission. Catalog material is produced to 99%+ HPLC purity. Every batch goes through 7-panel testing, and the resulting certificates of analysis are publicly verifiable — a prospective partner can look up lab results before placing a first order rather than after, and never as a paid add-on. Fulfillment is US-based, with orders shipping in 5–7 days.
The Wholesale Partner Program uses a 3-step application. Qualified businesses — med spas, clinics, telehealth operations, wellness centers, and resellers building their own catalogs — apply, are reviewed, and receive tier pricing disclosed as part of the process rather than negotiated blind on a call. Margin and volume outcomes vary widely by category, order size, and how a business is positioned, so the program does not publish outcome promises. What it does publish is the testing behind each batch.
If your business is evaluating research peptide suppliers and documentation quality is a real criterion rather than a checkbox, the Wholesale Partner Program application is the next step. Bring the questions in this article to it, and to every other supplier on your list — the ones worth working with will have answers ready.
For buyers comparing documentation across compound categories, Real Peptides publishes batch data across its Growth Factor & Tissue Signaling Research and Performance & Recovery Research collections, alongside widely stocked items such as BPC-157 and TB-500; the full catalog and the Wholesale Partner Program are at Real Peptides.
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA